These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 19567212

  • 1. Fludarabine phosphate for the first-line treatment of chronic lymphocytic leukaemia.
    Walker S, Palmer S, Erhorn S, Brent S, Dyker A, Ferrie L, Horsley W, Macfarlane K, White S, Thomas S.
    Health Technol Assess; 2009 Jun; 13 Suppl 1():35-40. PubMed ID: 19567212
    [Abstract] [Full Text] [Related]

  • 2. The clinical effectiveness and cost-effectiveness of rituximab for the first-line treatment of chronic lymphocytic leukaemia: an evidence review of the submission from Roche.
    Main C, Pitt M, Moxham T, Stein K.
    Health Technol Assess; 2010 Oct; 14(Suppl. 2):27-32. PubMed ID: 21047488
    [Abstract] [Full Text] [Related]

  • 3. Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia.
    Dretzke J, Barton P, Kaambwa B, Connock M, Uthman O, Bayliss S, Meads C.
    Health Technol Assess; 2010 Oct; 14(Suppl. 2):19-26. PubMed ID: 21047487
    [Abstract] [Full Text] [Related]

  • 4. Trastuzumab for the treatment of primary breast cancer in HER2-positive women: a single technology appraisal.
    Ward S, Pilgrim H, Hind D.
    Health Technol Assess; 2009 Jun; 13 Suppl 1():1-6. PubMed ID: 19567207
    [Abstract] [Full Text] [Related]

  • 5. Ofatumumab for the treatment of chronic lymphocytic leukaemia in patients who are refractory to fludarabine and alemtuzumab: a critique of the submission from GSK.
    Hoyle M, Crathorne L, Garside R, Hyde C.
    Health Technol Assess; 2011 May; 15 Suppl 1():61-7. PubMed ID: 21609654
    [Abstract] [Full Text] [Related]

  • 6. Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
    Mistry H, Nduka C, Connock M, Colquitt J, Mantopoulos T, Loveman E, Walewska R, Mason J.
    Pharmacoeconomics; 2018 Apr; 36(4):399-406. PubMed ID: 29222670
    [Abstract] [Full Text] [Related]

  • 7. The use of paclitaxel in the management of early stage breast cancer.
    Griffin S, Dunn G, Palmer S, Macfarlane K, Brent S, Dyker A, Erhorn S, Humphries C, White S, Horsley W, Ferrie L, Thomas S.
    Health Technol Assess; 2009 Jun; 13 Suppl 1():15-22. PubMed ID: 19567209
    [Abstract] [Full Text] [Related]

  • 8. Bortezomib for the treatment of multiple myeloma patients.
    Green C, Bryant J, Takeda A, Cooper K, Clegg A, Smith A, Stephens M.
    Health Technol Assess; 2009 Jun; 13 Suppl 1():29-33. PubMed ID: 19567211
    [Abstract] [Full Text] [Related]

  • 9. Cetuximab plus radiotherapy for the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Griffin S, Walker S, Sculpher M, White S, Erhorn S, Brent S, Dyker A, Ferrie L, Gilfillan C, Horsley W, Macfarlane K, Thomas S.
    Health Technol Assess; 2009 Jun; 13 Suppl 1():49-54. PubMed ID: 19567214
    [Abstract] [Full Text] [Related]

  • 10. Infliximab for the treatment of adults with psoriasis.
    Loveman E, Turner D, Hartwell D, Cooper K, Clegg A.
    Health Technol Assess; 2009 Jun; 13 Suppl 1():55-60. PubMed ID: 19567215
    [Abstract] [Full Text] [Related]

  • 11. Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer.
    Greenhalgh J, McLeod C, Bagust A, Boland A, Fleeman N, Dundar Y, Oyee J, Dickson R, Davis H, Green J, McKenna E, Pearson M.
    Health Technol Assess; 2010 Oct; 14(Suppl. 2):33-9. PubMed ID: 21047489
    [Abstract] [Full Text] [Related]

  • 12. Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma.
    Boland A, Bagust A, Hockenhull J, Davis H, Chu P, Dickson R.
    Health Technol Assess; 2009 Sep; 13 Suppl 2():41-8. PubMed ID: 19804688
    [Abstract] [Full Text] [Related]

  • 13. Docetaxel for the adjuvant treatment of early node-positive breast cancer: a single technology appraisal.
    Chilcott J, Lloyd Jones M, Wilkinson A.
    Health Technol Assess; 2009 Jun; 13 Suppl 1():7-13. PubMed ID: 19567208
    [Abstract] [Full Text] [Related]

  • 14. Cetuximab for the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Greenhalgh J, Bagust A, Boland A, Fleeman N, McLeod C, Dundar Y, Proudlove C, Shaw R.
    Health Technol Assess; 2009 Oct; 13 Suppl 3():49-54. PubMed ID: 19846029
    [Abstract] [Full Text] [Related]

  • 15. Rituximab for the first-line treatment of stage III/IV follicular non-Hodgkin's lymphoma.
    Dundar Y, Bagust A, Hounsome J, McLeod C, Boland A, Davis H, Walley T, Dickson R.
    Health Technol Assess; 2009 Jun; 13 Suppl 1():23-8. PubMed ID: 19567210
    [Abstract] [Full Text] [Related]

  • 16. Bendamustine versus chlorambucil for the first-line treatment of chronic lymphocytic leukemia in England and Wales: a cost-utility analysis.
    Woods B, Hawkins N, Dunlop W, O'Toole A, Bramham-Jones S.
    Value Health; 2012 Jun; 15(5):759-70. PubMed ID: 22867787
    [Abstract] [Full Text] [Related]

  • 17. Erlotinib for the treatment of relapsed non-small cell lung cancer.
    McLeod C, Bagust A, Boland A, Hockenhull J, Dundar Y, Proudlove C, Davis H, Green J, Macbeth F, Stevenson J, Walley T, Dickson R.
    Health Technol Assess; 2009 Jun; 13 Suppl 1():41-7. PubMed ID: 19567213
    [Abstract] [Full Text] [Related]

  • 18. Entecavir for the treatment of chronic hepatitis B infection.
    Shepherd J, Gospodarevskaya E, Frampton G, Cooper K.
    Health Technol Assess; 2009 Oct; 13 Suppl 3():31-6. PubMed ID: 19846026
    [Abstract] [Full Text] [Related]

  • 19. Rituximab for the treatment of rheumatoid arthritis.
    Bagust A, Boland A, Hockenhull J, Fleeman N, Greenhalgh J, Dundar Y, Proudlove C, Kennedy T, Moots R, Williamson P, Dickson R.
    Health Technol Assess; 2009 Sep; 13 Suppl 2():23-9. PubMed ID: 19804686
    [Abstract] [Full Text] [Related]

  • 20. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.
    Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, Hines J, Threatte GA, Larson RA, Cheson BD, Schiffer CA.
    N Engl J Med; 2000 Dec 14; 343(24):1750-7. PubMed ID: 11114313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.